Advanced search
Publication Cover
Renal Failure Volume 33, 2011 - Issue 2
Submit an article Journal homepage
787
Views
15
CrossRef citations to date
0
Altmetric
Laboratory Studies

Norcantharidin Attenuates Tubulointerstitial Fibrosis in Rat Models with Diabetic Nephropathy

Ying Li Division of Nephrology, The Second Xiangya Hospital, Research Institute of Nephrology, Central South University, Changsha, PR China; Key Laboratory of Nephrology and Blood Purification in Hunan, Changsha, PR ChinaCorrespondence[email protected] [email protected]
,
Qiong Chen Division of Nephrology, The Second Xiangya Hospital, Research Institute of Nephrology, Central South University, Changsha, PR China; Key Laboratory of Nephrology and Blood Purification in Hunan, Changsha, PR China; Division of Nephrology, Shanghai Tenth People's Hospital, Tongji University, Shanghai, PR China
,
Fu-You Liu Division of Nephrology, The Second Xiangya Hospital, Research Institute of Nephrology, Central South University, Changsha, PR China; Key Laboratory of Nephrology and Blood Purification in Hunan, Changsha, PR China
,
You-Ming Peng Division of Nephrology, The Second Xiangya Hospital, Research Institute of Nephrology, Central South University, Changsha, PR China; Key Laboratory of Nephrology and Blood Purification in Hunan, Changsha, PR China
,
Tao Hou Division of Nephrology, The Second Xiangya Hospital, Research Institute of Nephrology, Central South University, Changsha, PR China; Key Laboratory of Nephrology and Blood Purification in Hunan, Changsha, PR China
,
Shao-Bin Duan Division of Nephrology, The Second Xiangya Hospital, Research Institute of Nephrology, Central South University, Changsha, PR China; Key Laboratory of Nephrology and Blood Purification in Hunan, Changsha, PR China
,
Jun Li Division of Nephrology, The Second Xiangya Hospital, Research Institute of Nephrology, Central South University, Changsha, PR China; Key Laboratory of Nephrology and Blood Purification in Hunan, Changsha, PR China
,
Jun-Hui Luo Division of Nephrology, The Second Xiangya Hospital, Research Institute of Nephrology, Central South University, Changsha, PR China; Key Laboratory of Nephrology and Blood Purification in Hunan, Changsha, PR China
,
Lin Sun Division of Nephrology, The Second Xiangya Hospital, Research Institute of Nephrology, Central South University, Changsha, PR China; Key Laboratory of Nephrology and Blood Purification in Hunan, Changsha, PR China
&
Guang-Hui Ling Division of Nephrology, The Second Xiangya Hospital, Research Institute of Nephrology, Central South University, Changsha, PR China; Key Laboratory of Nephrology and Blood Purification in Hunan, Changsha, PR China
 show all
Pages 233-241 | Received 24 Oct 2010, Accepted 06 Jan 2011, Published online: 18 Feb 2011

REFERENCES

  • Magri CJ, Fava S. The role of tubular injury in diabetic nephropathy. Eur J Intern Med. 2009;20(6):551–555.
  • Hills CE, Squires PE. TGF-beta1-induced epithelial-to-mesenchymal transition and therapeutic intervention in diabetic nephropathy. Am J Nephrol. 2010;31(1):68–74.
  • Balakumar P, Arora MK, Ganti SS, Recent advances in pharmacotherapy for diabetic nephropathy: Current perspectives and future directions. Pharmacol Res. 2009; 60(1):24–32.
  • Liu FY, Li Y, Peng YM, Noncantharidin ameliorates proteinuria, associated tubulointerstitial inflammation and fibrosis in protein overload nephropathy. Am J Nephrol. 2008;28(3):465–477.
  • Liu FY, Sun Y, Sun L, Noncantharidin inhibits tubular epithelial mesenchymal transition by downregulating activation of Smad2/3 and snail. ASN Renal Week. 2009;abstract (number: 550493).
  • Katz A, Caramori ML, Sisson-Ross S, An increase in the cell component of the cortical interstitium antedates interstitial fibrosis in type 1 diabetic patients. Kidney Int. 2002; 61(6):2058–2066.
  • Tervaert TW, Mooyaart AL, Amann K, Pathologic classification of diabetic nephropathy. J Am Soc Nephrol. 2010;21(4):556–563.
  • Fioretto P, Mauer M. Histopathology of diabetic nephropathy. Semin Nephrol. 2007;27(2):195–207.
  • Parving H-H, Gall M-A, Skøtt P, Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int. 1992;41:758–762.
  • Gambara V, Mecca G, Remuzzi G, Heterogeneous nature of renal lesions in type II diabetes. J Am Soc Nephrol. 1993;3(8):1458–1466.
  • Massicot F, Dutertre-Catella H, Pham-Huy C, In vitro assessment of renal toxicity and inflammatory events of two protein phosphatase inhibitors cantharidin and nor-cantharidin. Basic Clin Pharmacol Toxicol. 2005;96(1):26–32.
  • Huang Y, Liu Q, Liu K, Suppression of growth of highly-metastatic human breast cancer cells by norcantharidin and its mechanisms of action. Cytotechnology. 2009;59(3):209.
  • Huang Y, Liu Q, Liu K, Suppression of growth of highly-metastatic human breast cancer cells by norcantharidin and its mechanisms of action. Cytotechnology. 2009;59(3):201–208.
  • Hill TA, Stewart SG, Ackland SP, Norcantharimides, synthesis and anticancer activity: Synthesis of new norcantharidin analogues and their anticancer evaluation. Bioorg Med Chem. 2007;15(18):6126–6134.
  • Bertini I, Calderone V, Fragai M, Structural basis of serine/threonine phosphatase inhibition by the archetypal small molecules cantharidin and norcantharidin. J Med Chem. 2009;52(15):4838–4843.
  • Baba Y, Hirukawa N, Tanohira N, Structure-based design of a highly selective catalytic site-directed inhibitor of Ser/Thr protein phosphatase 2B (calcineurin). J Am Chem Soc. 2003;125(32):9740–9749.
  • Baba Y, Hirukawa N, Sodeoka M. Optically active cantharidin analogues possessing selective inhibitory activity on Ser/Thr protein phosphatase 2B (calcineurin): Implications for the binding mode. Bioorg Med Chem. 2005;13(17):5164–5170.
  • Tumlin JA, Someren JT, Swanson CE, Expression of calcineurin activity and -subunit isoforms in specific segments of the rat nephron. Am J Physiol Renal Physiol. 1995;269(4 pt. 2):F558–F563.
  • Gooch JL. An emerging role for calcineurin A in the development and function of the kidney. Am J Physiol Renal Physiol. 2006;290(4):769–776.
  • Cobbs SL, Gooch JL. NFATc is required for TGF beta-mediated transcriptional regulation of fibronectin. Biochem Biophys Res Commun. 2007;362(2):288–294.
  • Gooch JL, Barnes JL, Garcia S, Calcineurin is activated in diabetes and is required for glomerular hypertrophy and ECM accumulation. Am J Physiol Renal. 2003;284(1):144–154.
  • Gooch JL, Gorin Y, Zhang BX, Involvement of calcineurin in transforming growth factor-β mediated regulation of extracellular matrix accumulation. J Biol Chem. 2004; 279(15):15561–15570.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.